Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
This week we welcome Paul Peter Tak! CEO and President of Candel Therapeutics
From a professorship in his native Netherlands to the SVP, Chief Immunology Officer, and global development leader at GSK, and from leading small biotechs such as Tempero and Kintai to entering the venture world as a Flagship partner.
Now, he is the CEO and President of Candel Therapeutics – a promising clinical immunotherapy company in the fight against cancer.
Enjoy and stay tuned.